VBIV: Nilai perusahaan marang bathi resik VBI Vaccines, Inc.

VBI Vaccines Inc - logo grafis emiten VBIV

VBI Vaccines Inc. (VBIV) business relies on the mass production of antigens with minimal costs following the development stage. The stable, glitch-free operation of sterile lines guarantees high capacity utilization, while an extensive network of regional suppliers protects exports from disruptions. The price action of the securities confirms these successes, with the current indicator standing at 0.00, highlighting the operational efficiency of this biopharmaceutical company.

VBIV - Pangali P/E VBI Vaccines ing rentang 04.07.2022 - 10.08.2024

Rincian analitis perusahaan VBI Vaccines Inc (VBIV)

- rega lan prakiraan konsensus rega:
Analisis komprehensif perusahaan:VBI Vaccines Inc.
Barang unggulan VBI Vaccines, Inc.

Business valuation requires an analysis of the ratio of market capitalization to net income. This coefficient determines the premium investors are willing to pay for the issuer's future earnings. The trend in the forward P/E of VBI Vaccines Inc. (VBIV) reflects market confidence in the efficiency of its operating model. For VBI Vaccines Inc. (VBIV), a stable cash flow from the sale of hepatitis B vaccines reduces the volatility of the multiple. Patent protection of assets confirms the fundamental validity of current price expectations.